Subject matters | Details | Categories |
---|---|---|
Economic Development, Health
|
Working with the government on an open and inclusive regulatory regime for generic pharmaceuticals that continues to allow the industry to grow in Canada, and discuss with the government how Apotex can work with them to ensure the security and increase the self-sufficiency of Canada’s drug supply, how the government can help ensure access to international markets, and how the government can utilize generic and biosimilar medications to make pharmacare and other drug programs more sustainable.
|
Policies or Program, Legislative Proposal, Bill or Resolution, Regulation
|
Address:
200 Barmac Drive
Toronto, ON M9L 2S8
Canada
Telephone number:
416-401-7530
Chris Fournier, Vice President, Market Access and Government Relations
Apotex Inc. is not a subsidiary of any other parent companies.
Apotex Inc. is not a coalition.
The activities of Apotex Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Apotex Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Christopher Froggatt | Designated public offices held
Firm: Loyalist Public Affairs